Karyopharm Therapeutics | KPTI - Market Capitalization


Karyopharm Therapeutics reported $6.9M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Abbott USD 171.01B 12.96B Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 151M 143M Nov/2026
Merck USD 375.59B 17.09B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Novartis USD 328.21B 54.92B Nov/2026
Pfizer USD 169.88B 6.47B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Takeda JPY 9.26T 1.06T Sep/2026
Tectonic Therapeutic USD 649M 69M Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Xencor USD 2.14B 281M Nov/2026